Journals / Retina-Vitreus / 2004 / Cilt: 12 - Sayı: 1

Choroidal neovascularization in central serous chorioretinopathy

Santral seröz korioretinopatide koroidal neovaskülarizasyon

Pages
54–57
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After the diagnosis was confirmed by ICG the juxtafoveal membrane was covered with Argon laser photocoagulation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Central serous chorioretinopathy is a well known and generally a self limiting disease.
📊
Key Findings & Data:A healthy 39 year-old woman had a 1-week history of decreased vision in her right eye.
💡
Conclusion & Impact:After the diagnosis was confirmed by ICG the juxtafoveal membrane was covered with Argon laser photocoagulation
🔬Design:Lab & Field Experiment
📍Scope:Comprehensive Sample
⚙️Variables:Koroidal neovaskülarizasyon · Choroidal Neovascularization

Abstract

Central serous chorioretinopathy is a well known and generally a self limiting disease. Retina pigment epithelium defects and atrophies are sources of visual loss in the relapsing attacks. Choroidal neovascular membrane formation is a rare finding and can be responsible of severe visual loss during the course of the disease. A healthy 39 year-old woman had a 1-week history of decreased vision in her right eye. She had a three-discdiameter central serous macular detachment of sensory retina and a deep gray-white membrane and subretinal hemorrhage superotemporal to the macular detachment. Early angiograms revealed hyperfluorescence of superotemporal juxtafoveal membrane and the leakage increased in size and intensity as the angiogram progressed. Late angiograms demonstrated pooling of fluorescence in the serous retinal detachment. After the diagnosis was confirmed by ICG the juxtafoveal membrane was covered with Argon laser photocoagulation

Özet

antral Seröz Korioretinopati iyi tanımlanmış ve genellikle kendi kendini sınırlayan bir hastalıktır. Tekrarlayan ataklar sonrası oluşan retina pigment epitel kayıpları görme kaybının esas nedeni olarak karşımıza çıkmaktadır. Koroid neovaskülarizasyonu nadir bir bulgu olmakla birlikte hastalığın seyri sırasında ciddi görme kaybına neden olabilir. 39 yaşında sağlıklı kadın hasta sağ gözünde bir haftadır devam eden görme azalması şikayetiyle başvurdu. Fundus muayenesinde sağ gözde makulada yaklaşık 3 disk çapında seröz retina dekolmanı ve fovea üst temporalinde, seröz dekolmanın altında, derin yerleşimli grimsi-beyaz renkli membran yapısı ve subretinal hemoraji tespit edildi. Fundus floresein anjiografi incelemesinde; üst temporaldeki membran bölgesinde hiperfloresans ve anjiogramın fazları ilerledikçe sızıntının büyüklüğünde ve yoğunluğunda artış gözlendi. Anjiogramın geç fazlarında seröz dekolmanın altında floresein göllenmesi izlendi. Tanı ICG ile doğrulandıktan sonra jukstafoveal membranın üzeri tamamen kapatılacak şekilde argon lazer fotokoagülasyon uygulandı.

🔖

Cite This Article

GÜNGÖR, Ö., ŞENGÜN, A., GÜL, G., GÜRSEL, R., AKBATUR, H. H., HASIRİPİ, H. (2004). Choroidal neovascularization in central serous chorioretinopathy. Retina-Vitreus, Cilt: 12 - Sayı: 1, 54–57. https://ajindex.com/articles/307981

References (18)

  1. Berger AR,Oik RJ, Burgess D.: Central serous choroidopathy in patients över 50 years of age.Ophthalmic Surg 1991
  2. 590 2. Blake A. Cooper, MD
  3. Matthew A. et al.: Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy. Am J Ophthalmol 2000
  4. 191 3. Shatz H, Madeira D, Johnson RN, et al.: Central serous chorioretinopathy occurring in parents 60 years of age or order.Ophthalmology 1992
  5. 67 4. Spaide RF, Hall L, Haas A, et al.: Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996
  6. 213 5. Watzke RC, Burton TC, Woolson RF.: Direct and indirect lazer photocoagulation of central serous choroidopathy. Am J Ophthalmol. 1979
  7. 918 6. Gilbert CM, Owens SL, Smith PD, et al.: Long-term follow-up of central serous retinopathy. Br J Ophthalmol. 1984
  8. 820 7. Robertson D, llstrup D.: Direct, indirect and sham lazer photocoagulation in the management of central serous retinopathy. Am J Ophthalmol. 1983
  9. 466 8. American Academy of Ophthalmology -Retina and Vitreous 2002-2003 9. Demircan N, Anlı A, Soylu M, ve ark.: Santral seröz korioretinopatide klinik bulgular ve prognoz. Ret-Vit 1996
  10. Güven D, Aksünger A, Or M, ve ark.: Santral seröz korioretinopatide floressein anjiografik görünümler. Ret-Vit 1994
  11. İlici Ö, Yücel A, Avcı R, ve ark.: Santral seröz korioretinopatide asetazolamid ve beta bloker tedavisinin sonuçları. TOD XX. Ulus Kong. Bült. 1996
  12. Müftüoğlu G, Solmaz A, Özkan Ş, et al.: Santral seröz korioretinopatide 'indocyanine Green' anjiografi. Ret- Vit 1997
  13. Corticosteroid-induced central serous chorioretinopathy in patients with ocular inflammatory disorders. Klin Monatsbl Augenheilkd 2002
  14. Central serous chorioretinopathy and glucocorticoids. Survey ophthalmol 2002
  15. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 2003
  16. Bilateral central serous chorioretinopathy in a patient treated with systemic cortico-steroids for Non Hodgkm Lymphoma. Eur J Ophthalmol 2002
  17. Graft-vs-host disease associated conjunctival chemozis and central serous chorioretinopathy after bone marrow transplant. Am J Ophthalmol 2002
  18. Central Serous Chorioretinopathy after bone marrow transplantation. Am J Ophthalmol 2001,-131:804,805. 19. Gass JD. Stereoscopic Atlas of Macular Diseases: Diag